- Home
- SPNT vs AAPG Comparison
SPNT vs AAPG Comparison
Compare SPNT & AAPG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | SPNT | AAPG |
|---|---|---|
| Founded | 2011 | 2009 |
| Country | Bermuda | China |
| Employees | N/A | N/A |
| Industry | Property-Casualty Insurers | Biotechnology: Pharmaceutical Preparations |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.3B | 2.6B |
| IPO Year | N/A | 2025 |
Fundamental Metrics
Financial Performance| Metric | SPNT | AAPG |
|---|---|---|
| Price | $19.97 | $27.77 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 3 | 5 |
| Target Price | $24.00 | ★ $48.50 |
| AVG Volume (30 Days) | ★ 744.1K | 3.7K |
| Earning Date | 02-17-2026 | 03-26-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | ★ 1.45 | N/A |
| Revenue | ★ $2,859,100,000.00 | $54,524,554.00 |
| Revenue This Year | $0.89 | N/A |
| Revenue Next Year | $6.87 | $368.64 |
| P/E Ratio | $14.03 | ★ N/A |
| Revenue Growth | ★ 6.92 | N/A |
| 52 Week Low | $13.26 | $16.50 |
| 52 Week High | $22.89 | $48.45 |
Technical Indicators
Market Signals| Indicator | SPNT | AAPG |
|---|---|---|
| Relative Strength Index (RSI) | 38.01 | 42.22 |
| Support Level | $19.72 | $27.48 |
| Resistance Level | $20.59 | $28.49 |
| Average True Range (ATR) | 0.59 | 0.49 |
| MACD | -0.20 | 0.21 |
| Stochastic Oscillator | 9.38 | 37.17 |
Price Performance
Historical ComparisonAbout SPNT SiriusPoint Ltd.
SiriusPoint Ltd provides property and casualty reinsurance coverage to insurance and reinsurance companies in the United States, Canada, Bermuda, the United Kingdom, and Europe. The company operates through two operating segments: Reinsurance and Insurance & Services. The company's product portfolio consists of reinsurance contracts for property insurance including both residential and commercial properties, workers' compensation, personal automobile, businesses' general liability insurance, professional liability insurance to protect professional advisors and service providers, agriculture insurance, and mortgage insurance. The majority of the revenue is generated from its Insurance & Services segment.
About AAPG Ascentage Pharma Group International American Depository Shares
Ascentage Pharma Group International is a clinical-stage biotechnology company engaged in the development and sales of novel small-scale therapies for cancers, hepatitis B virus, or HBV, and certain age-related diseases. It focuses on developing therapies that inhibit protein-protein interactions to restore apoptosis or programmed cell death. The Group has one reportable operating segment, which is discovering, developing, and commercializing therapies to address medical needs in hematological malignancies. The company's geographical segments include the United States and Mainland China.